ArticleBMC cancer2016

FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine.

Dannel Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.